SARS CoV 2 News and Research

RSS

Do two or more mRNA vaccine doses provide additional protection in patients with prior COVID-19 infection?

Researchers conducted a retrospective cohort study among vaccinated and unvaccinated COVID-19 patients between December 16, 2020, and March 15, 2022, in the USA.

30 Mar 2023

How does acute COVID-19 or COVID vaccination affect menstruation?

Researchers examined the potential impact of coronavirus disease 2019 vaccination and disease on changes in the menstrual cycle.

30 Mar 2023

Study indicates interleukin-6-dependant pathway dysregulation as a key druggable feature of COVID-19

Researchers identified an interleukin 6 dependent alternative pathway as a therapeutic strategy against coronavirus disease 2019.

30 Mar 2023

From an economic crisis to a global pandemic: how have trends in emotional distress changed between 2009 and 2021?

Researchers investigated global trends in emotional discomfort.

30 Mar 2023

The decision-making process for the launch of trials for COVID-19 repurposed antivirals

Researchers reviewed the decision-making process for performing randomized clinical trials for three drugs under consideration for repurposing for COVID-19 treatment: remdesivir, molnupiravir, and tenofovir disoproxil fumarate.

30 Mar 2023

Study finds that current antiviral drugs retain efficacy against newly emerged Omicron subvariants

Researchers assessed the efficacy of antiviral medications against novel Omicron subvariants.

30 Mar 2023

Study finds minimal impact of SARS-CoV-2 genome variability on current diagnostic molecular systems

The authors of a new study under review at the journal Scientific Reports and currently posted to the Research Square preprint* server proposed a novel analysis pipeline to help identify mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) primer regions.

29 Mar 2023

SARS-CoV-2 infection disrupts the RNA modifications, study reports

Coronavirus disease (COVID-19) hijacks parts of infected cells' vital RNA machinery, thereby blocking important functions in the cells. These damaging changes in the RNA can likely be reversed, potentially leading to new drugs against COVID-19, University of Gothenburg researchers show.

29 Mar 2023

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

Researchers found that, despite being heavily immunocompromised, hematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.

29 Mar 2023

The emergence of lateral flow assays in diagnostics

In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics.

From Sartorius Lab Instruments GmbH & Co. KG 29 Mar 2023

Newly designed molecule disrupts the infection mechanism of SARS-CoV-2

A team of scientists led by the Department of Energy's Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

28 Mar 2023

COVID-19 activates endogenous retroviruses within our genome

Researchers assess the impact of SARS-CoV-2 infection on endogenous retroviruses of the LTR69 subfamily.

28 Mar 2023

How do viral infections cause autoimmune diseases?

Researchers describe the pathological mechanisms of virus-induced autoimmune diseases.

28 Mar 2023

Global mapping of bushmeat activity to improve zoonotic spillover surveillance

Researchers use geospatial models based to predict the rural global areas of bushmeat activity.

28 Mar 2023

New nanomaterials-based sensor detects flu and COVID-19 in just 10 seconds

Have a cough, sore throat and congestion? Any number of respiratory viruses could be responsible. Conventional tests can identify certain likely culprits by relying on chemical reactions, but some researchers want to swap chemistry for electrical changes sensed by nanomaterials.

28 Mar 2023

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

Researchers have designed a molecule that slows the effects of one of SARS-CoV-2's more dangerous components – an enzyme called a protease that cuts off the immune system's communications and helps the virus replicate.

28 Mar 2023

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Researchers assessed the impact of BCG vaccination on the protection provided by SARS-CoV-2 vaccination.

28 Mar 2023

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.

28 Mar 2023

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

In a recent case report published in the U.S. Centers for Disease Control and Prevention’s (CDC) journal Emerging Infectious Diseases, researchers reported a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Nocardia pseudobrasiliensis concomitant infection.

27 Mar 2023

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

SARS CoV 2 News and Research

Do two or more mRNA vaccine doses provide additional protection in patients with prior COVID-19 infection?

How does acute COVID-19 or COVID vaccination affect menstruation?

Study indicates interleukin-6-dependant pathway dysregulation as a key druggable feature of COVID-19

From an economic crisis to a global pandemic: how have trends in emotional distress changed between 2009 and 2021?

The decision-making process for the launch of trials for COVID-19 repurposed antivirals

Study finds that current antiviral drugs retain efficacy against newly emerged Omicron subvariants

Study finds minimal impact of SARS-CoV-2 genome variability on current diagnostic molecular systems

SARS-CoV-2 infection disrupts the RNA modifications, study reports

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

The emergence of lateral flow assays in diagnostics

Newly designed molecule disrupts the infection mechanism of SARS-CoV-2

COVID-19 activates endogenous retroviruses within our genome

How do viral infections cause autoimmune diseases?

Global mapping of bushmeat activity to improve zoonotic spillover surveillance

New nanomaterials-based sensor detects flu and COVID-19 in just 10 seconds

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

New study suggests broad neutralizing antibody could provide three years of COVID protection

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News